SCHEMBL500668

SCHEMBL500668

C=CCOC(=O)CCN.[NaH]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
PKM P14618 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP3A4 P08684 1/20 0.42
ALDH1A1 P00352 6/20 0.41
GAA P10253 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 2/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
CYP1A2 P05177 1/20 0.38
EPHX2 P34913 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
CASP1 P29466 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL88550 0.98
Hydrochloric Acid SCHEMBL30310990 0.96 TSHR (0.53) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
Ethylenediamine SCHEMBL7747400 0.89 TSHR (0.55) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
Propionic Acid SCHEMBL11195267 0.87 TSHR (0.54) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL28545578 0.86 TSHR (0.61) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
Trifluoroacetic Acid SCHEMBL21802650 0.85 TSHR (0.45) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL1614567 0.85 TSHR (0.61) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL56403 0.84 TSHR (0.63) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
SCHEMBL15894553 0.83 TSHR (0.65) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1
Benzene SCHEMBL28110883 0.82 PKM (0.59) TSHRPKMSMN1; SMN2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8105637-B2 health food and drink contains the pure plant extract, is for patients with abnormality in cerebral blood flow and metabolism of brain disorder; nutraceuticals; free of proanthocyanidins SHIMADA SHINJI (JP) 2012-01-31 US disclosed
US-20080254126-A1 Composition comprising nanoparticle ginkgo biloba extract with the effect of brain function activation SHIMADA SHINJI 2008-10-16 US disclosed